Global Afamelanotide Market Growth 2026-2032
The global Afamelanotide market size is predicted to grow from US$ 66.33 million in 2025 to US$ 113 million in 2032; it is expected to grow at a CAGR of 8.1% from 2026 to 2032.
Afamelanotide is a synthetic peptide drug, an analog of alpha-melanocyte-stimulating hormone (?-MSH), used as a subcutaneous implant to prevent painful skin reactions from sun exposure in patients with the rare genetic disorder Erythropoietic Protoporphyria (EPP). It works by stimulating melanin (specifically eumelanin) production in the skin, which blocks light and reduces the severe pain, redness, and swelling caused by EPP. Administered as a small implant under the skin, it's released slowly over about two months.
Global production of afanotide is projected to reach 3,000 vials by 2025, with an average price of US$22,600 per vial. Gross profit margins typically remain at a high level of 70% to 85%.
Afamelanotide is a synthetic analog of melanocyte-stimulating hormone. Its upstream industry chain mainly consists of peptide raw materials and amino acid monomers, solid-phase synthesis resins and reagents, solvents, lyophilization excipients, sterile packaging materials, and bioanalytical testing services. The upstream focus lies in high-purity peptide synthesis and consistent quality control. Downstream demand is highly concentrated in rare disease and niche dermatology treatments, with its primary use in improving phototolerance for patients with erythropoietic protoporphyria. End users are mainly specialized hospitals, rare disease treatment centers, and reimbursement systems. Given the small and clearly defined patient population, downstream stakeholders prioritize clinical efficacy, safety, ease of administration, and long-term adherence. Payment is often supported by public insurance, special funds, or premium commercial insurance, resulting in relatively low price sensitivity but high requirements for clinical evidence. As real-world data accumulates, downstream applications are gradually expanding toward additional photosensitivity-related indications, while remaining focused on specialist channels and academic promotion.
In terms of industry trends, Afamelanotide products are moving toward indication expansion, optimized delivery methods, and stronger real-world evidence generation. Key growth drivers include supportive orphan drug policies, incentives for rare disease development, and increasing advocacy from patient organizations. Major constraints include a limited patient base that caps market size, high development and regulatory costs, complex manufacturing barriers, and strong dependence on a single core product.
LP Information, Inc. (LPI) ' newest research report, the ?Afamelanotide Industry Forecast? looks at past sales and reviews total world Afamelanotide sales in 2025, providing a comprehensive analysis by region and market sector of projected Afamelanotide sales for 2026 through 2032. With Afamelanotide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Afamelanotide industry.
This Insight Report provides a comprehensive analysis of the global Afamelanotide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Afamelanotide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Afamelanotide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Afamelanotide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Afamelanotide.
This report presents a comprehensive overview, market shares, and growth opportunities of Afamelanotide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Afamelanotide is a synthetic peptide drug, an analog of alpha-melanocyte-stimulating hormone (?-MSH), used as a subcutaneous implant to prevent painful skin reactions from sun exposure in patients with the rare genetic disorder Erythropoietic Protoporphyria (EPP). It works by stimulating melanin (specifically eumelanin) production in the skin, which blocks light and reduces the severe pain, redness, and swelling caused by EPP. Administered as a small implant under the skin, it's released slowly over about two months.
Global production of afanotide is projected to reach 3,000 vials by 2025, with an average price of US$22,600 per vial. Gross profit margins typically remain at a high level of 70% to 85%.
Afamelanotide is a synthetic analog of melanocyte-stimulating hormone. Its upstream industry chain mainly consists of peptide raw materials and amino acid monomers, solid-phase synthesis resins and reagents, solvents, lyophilization excipients, sterile packaging materials, and bioanalytical testing services. The upstream focus lies in high-purity peptide synthesis and consistent quality control. Downstream demand is highly concentrated in rare disease and niche dermatology treatments, with its primary use in improving phototolerance for patients with erythropoietic protoporphyria. End users are mainly specialized hospitals, rare disease treatment centers, and reimbursement systems. Given the small and clearly defined patient population, downstream stakeholders prioritize clinical efficacy, safety, ease of administration, and long-term adherence. Payment is often supported by public insurance, special funds, or premium commercial insurance, resulting in relatively low price sensitivity but high requirements for clinical evidence. As real-world data accumulates, downstream applications are gradually expanding toward additional photosensitivity-related indications, while remaining focused on specialist channels and academic promotion.
In terms of industry trends, Afamelanotide products are moving toward indication expansion, optimized delivery methods, and stronger real-world evidence generation. Key growth drivers include supportive orphan drug policies, incentives for rare disease development, and increasing advocacy from patient organizations. Major constraints include a limited patient base that caps market size, high development and regulatory costs, complex manufacturing barriers, and strong dependence on a single core product.
LP Information, Inc. (LPI) ' newest research report, the ?Afamelanotide Industry Forecast? looks at past sales and reviews total world Afamelanotide sales in 2025, providing a comprehensive analysis by region and market sector of projected Afamelanotide sales for 2026 through 2032. With Afamelanotide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Afamelanotide industry.
This Insight Report provides a comprehensive analysis of the global Afamelanotide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Afamelanotide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Afamelanotide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Afamelanotide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Afamelanotide.
This report presents a comprehensive overview, market shares, and growth opportunities of Afamelanotide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Subcutaneous Implants
- Injectables
- Transdermal Patches
- Oral Preparations
- Topical Preparations
- ?-MSH Analogs
- Acetate Derivatives
- Free Peptide Derivatives
- Long-Acting Modified Derivatives
- MC1R Selective Agonists
- Melanin Synthesis Stimulants
- Anti-Inflammatory Agents
- Neuroprotective Agents
- Hematologic Disorders
- Skin Pigmentary Disorders
- Acute Diseases
- Autoimmune Diseases
- Neurodegenerative Diseases
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Clinuvel Pharmaceuticals
- Evonik Industries
- Hangzhou Go Top Peptide Biotech
- Zhejiang Hengtengfu
- Wepon
- What is the 10-year outlook for the global Afamelanotide market?
- What factors are driving Afamelanotide market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Afamelanotide market opportunities vary by end market size?
- How does Afamelanotide break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Afamelanotide Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Afamelanotide by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Afamelanotide by Country/Region, 2021, 2025 & 2032
2.2 Afamelanotide Segment by Type
2.2.1 Subcutaneous Implants
2.2.2 Injectables
2.2.3 Transdermal Patches
2.2.4 Oral Preparations
2.2.5 Topical Preparations
2.2.6 Afamelanotide Sales by Type
2.2.6.1 Global Afamelanotide Sales Market Share by Type (2021-2026)
2.2.6.2 Global Afamelanotide Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Afamelanotide Sale Price by Type (2021-2026)
2.3 Afamelanotide Segment by Chemical Structure
2.3.1 ?-MSH Analogs
2.3.2 Acetate Derivatives
2.3.3 Free Peptide Derivatives
2.3.4 Long-Acting Modified Derivatives
2.3.5 Afamelanotide Sales by Chemical Structure
2.3.5.1 Global Afamelanotide Sales Market Share by Chemical Structure (2021-2026)
2.3.5.2 Global Afamelanotide Revenue and Market Share by Chemical Structure (2021-2026)
2.3.5.3 Global Afamelanotide Sale Price by Chemical Structure (2021-2026)
2.4 Afamelanotide Segment by Pharmacological Effects
2.4.1 MC1R Selective Agonists
2.4.2 Melanin Synthesis Stimulants
2.4.3 Anti-Inflammatory Agents
2.4.4 Neuroprotective Agents
2.4.5 Afamelanotide Sales by Pharmacological Effects
2.4.5.1 Global Afamelanotide Sales Market Share by Pharmacological Effects (2021-2026)
2.4.5.2 Global Afamelanotide Revenue and Market Share by Pharmacological Effects (2021-2026)
2.4.5.3 Global Afamelanotide Sale Price by Pharmacological Effects (2021-2026)
2.5 Afamelanotide Segment by Application
2.5.1 Hematologic Disorders
2.5.2 Skin Pigmentary Disorders
2.5.3 Acute Diseases
2.5.4 Autoimmune Diseases
2.5.5 Neurodegenerative Diseases
2.5.6 Afamelanotide Sales by Application
2.5.6.1 Global Afamelanotide Sale Market Share by Application (2021-2026)
2.5.6.2 Global Afamelanotide Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Afamelanotide Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Afamelanotide Breakdown Data by Company
3.1.1 Global Afamelanotide Annual Sales by Company (2021-2026)
3.1.2 Global Afamelanotide Sales Market Share by Company (2021-2026)
3.2 Global Afamelanotide Annual Revenue by Company (2021-2026)
3.2.1 Global Afamelanotide Revenue by Company (2021-2026)
3.2.2 Global Afamelanotide Revenue Market Share by Company (2021-2026)
3.3 Global Afamelanotide Sale Price by Company
3.4 Key Manufacturers Afamelanotide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Afamelanotide Product Location Distribution
3.4.2 Players Afamelanotide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AFAMELANOTIDE BY GEOGRAPHIC REGION
4.1 World Historic Afamelanotide Market Size by Geographic Region (2021-2026)
4.1.1 Global Afamelanotide Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Afamelanotide Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Afamelanotide Market Size by Country/Region (2021-2026)
4.2.1 Global Afamelanotide Annual Sales by Country/Region (2021-2026)
4.2.2 Global Afamelanotide Annual Revenue by Country/Region (2021-2026)
4.3 Americas Afamelanotide Sales Growth
4.4 APAC Afamelanotide Sales Growth
4.5 Europe Afamelanotide Sales Growth
4.6 Middle East & Africa Afamelanotide Sales Growth
5 AMERICAS
5.1 Americas Afamelanotide Sales by Country
5.1.1 Americas Afamelanotide Sales by Country (2021-2026)
5.1.2 Americas Afamelanotide Revenue by Country (2021-2026)
5.2 Americas Afamelanotide Sales by Type (2021-2026)
5.3 Americas Afamelanotide Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Afamelanotide Sales by Region
6.1.1 APAC Afamelanotide Sales by Region (2021-2026)
6.1.2 APAC Afamelanotide Revenue by Region (2021-2026)
6.2 APAC Afamelanotide Sales by Type (2021-2026)
6.3 APAC Afamelanotide Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Afamelanotide by Country
7.1.1 Europe Afamelanotide Sales by Country (2021-2026)
7.1.2 Europe Afamelanotide Revenue by Country (2021-2026)
7.2 Europe Afamelanotide Sales by Type (2021-2026)
7.3 Europe Afamelanotide Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Afamelanotide by Country
8.1.1 Middle East & Africa Afamelanotide Sales by Country (2021-2026)
8.1.2 Middle East & Africa Afamelanotide Revenue by Country (2021-2026)
8.2 Middle East & Africa Afamelanotide Sales by Type (2021-2026)
8.3 Middle East & Africa Afamelanotide Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Afamelanotide
10.3 Manufacturing Process Analysis of Afamelanotide
10.4 Industry Chain Structure of Afamelanotide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Afamelanotide Distributors
11.3 Afamelanotide Customer
12 WORLD FORECAST REVIEW FOR AFAMELANOTIDE BY GEOGRAPHIC REGION
12.1 Global Afamelanotide Market Size Forecast by Region
12.1.1 Global Afamelanotide Forecast by Region (2027-2032)
12.1.2 Global Afamelanotide Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Afamelanotide Forecast by Type (2027-2032)
12.7 Global Afamelanotide Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Clinuvel Pharmaceuticals
13.1.1 Clinuvel Pharmaceuticals Company Information
13.1.2 Clinuvel Pharmaceuticals Afamelanotide Product Portfolios and Specifications
13.1.3 Clinuvel Pharmaceuticals Afamelanotide Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Clinuvel Pharmaceuticals Main Business Overview
13.1.5 Clinuvel Pharmaceuticals Latest Developments
13.2 Evonik Industries
13.2.1 Evonik Industries Company Information
13.2.2 Evonik Industries Afamelanotide Product Portfolios and Specifications
13.2.3 Evonik Industries Afamelanotide Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Evonik Industries Main Business Overview
13.2.5 Evonik Industries Latest Developments
13.3 Hangzhou Go Top Peptide Biotech
13.3.1 Hangzhou Go Top Peptide Biotech Company Information
13.3.2 Hangzhou Go Top Peptide Biotech Afamelanotide Product Portfolios and Specifications
13.3.3 Hangzhou Go Top Peptide Biotech Afamelanotide Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Hangzhou Go Top Peptide Biotech Main Business Overview
13.3.5 Hangzhou Go Top Peptide Biotech Latest Developments
13.4 Zhejiang Hengtengfu
13.4.1 Zhejiang Hengtengfu Company Information
13.4.2 Zhejiang Hengtengfu Afamelanotide Product Portfolios and Specifications
13.4.3 Zhejiang Hengtengfu Afamelanotide Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Zhejiang Hengtengfu Main Business Overview
13.4.5 Zhejiang Hengtengfu Latest Developments
13.5 Wepon
13.5.1 Wepon Company Information
13.5.2 Wepon Afamelanotide Product Portfolios and Specifications
13.5.3 Wepon Afamelanotide Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Wepon Main Business Overview
13.5.5 Wepon Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Afamelanotide Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Afamelanotide by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Afamelanotide by Country/Region, 2021, 2025 & 2032
2.2 Afamelanotide Segment by Type
2.2.1 Subcutaneous Implants
2.2.2 Injectables
2.2.3 Transdermal Patches
2.2.4 Oral Preparations
2.2.5 Topical Preparations
2.2.6 Afamelanotide Sales by Type
2.2.6.1 Global Afamelanotide Sales Market Share by Type (2021-2026)
2.2.6.2 Global Afamelanotide Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Afamelanotide Sale Price by Type (2021-2026)
2.3 Afamelanotide Segment by Chemical Structure
2.3.1 ?-MSH Analogs
2.3.2 Acetate Derivatives
2.3.3 Free Peptide Derivatives
2.3.4 Long-Acting Modified Derivatives
2.3.5 Afamelanotide Sales by Chemical Structure
2.3.5.1 Global Afamelanotide Sales Market Share by Chemical Structure (2021-2026)
2.3.5.2 Global Afamelanotide Revenue and Market Share by Chemical Structure (2021-2026)
2.3.5.3 Global Afamelanotide Sale Price by Chemical Structure (2021-2026)
2.4 Afamelanotide Segment by Pharmacological Effects
2.4.1 MC1R Selective Agonists
2.4.2 Melanin Synthesis Stimulants
2.4.3 Anti-Inflammatory Agents
2.4.4 Neuroprotective Agents
2.4.5 Afamelanotide Sales by Pharmacological Effects
2.4.5.1 Global Afamelanotide Sales Market Share by Pharmacological Effects (2021-2026)
2.4.5.2 Global Afamelanotide Revenue and Market Share by Pharmacological Effects (2021-2026)
2.4.5.3 Global Afamelanotide Sale Price by Pharmacological Effects (2021-2026)
2.5 Afamelanotide Segment by Application
2.5.1 Hematologic Disorders
2.5.2 Skin Pigmentary Disorders
2.5.3 Acute Diseases
2.5.4 Autoimmune Diseases
2.5.5 Neurodegenerative Diseases
2.5.6 Afamelanotide Sales by Application
2.5.6.1 Global Afamelanotide Sale Market Share by Application (2021-2026)
2.5.6.2 Global Afamelanotide Revenue and Market Share by Application (2021-2026)
2.5.6.3 Global Afamelanotide Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Afamelanotide Breakdown Data by Company
3.1.1 Global Afamelanotide Annual Sales by Company (2021-2026)
3.1.2 Global Afamelanotide Sales Market Share by Company (2021-2026)
3.2 Global Afamelanotide Annual Revenue by Company (2021-2026)
3.2.1 Global Afamelanotide Revenue by Company (2021-2026)
3.2.2 Global Afamelanotide Revenue Market Share by Company (2021-2026)
3.3 Global Afamelanotide Sale Price by Company
3.4 Key Manufacturers Afamelanotide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Afamelanotide Product Location Distribution
3.4.2 Players Afamelanotide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AFAMELANOTIDE BY GEOGRAPHIC REGION
4.1 World Historic Afamelanotide Market Size by Geographic Region (2021-2026)
4.1.1 Global Afamelanotide Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Afamelanotide Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Afamelanotide Market Size by Country/Region (2021-2026)
4.2.1 Global Afamelanotide Annual Sales by Country/Region (2021-2026)
4.2.2 Global Afamelanotide Annual Revenue by Country/Region (2021-2026)
4.3 Americas Afamelanotide Sales Growth
4.4 APAC Afamelanotide Sales Growth
4.5 Europe Afamelanotide Sales Growth
4.6 Middle East & Africa Afamelanotide Sales Growth
5 AMERICAS
5.1 Americas Afamelanotide Sales by Country
5.1.1 Americas Afamelanotide Sales by Country (2021-2026)
5.1.2 Americas Afamelanotide Revenue by Country (2021-2026)
5.2 Americas Afamelanotide Sales by Type (2021-2026)
5.3 Americas Afamelanotide Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Afamelanotide Sales by Region
6.1.1 APAC Afamelanotide Sales by Region (2021-2026)
6.1.2 APAC Afamelanotide Revenue by Region (2021-2026)
6.2 APAC Afamelanotide Sales by Type (2021-2026)
6.3 APAC Afamelanotide Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Afamelanotide by Country
7.1.1 Europe Afamelanotide Sales by Country (2021-2026)
7.1.2 Europe Afamelanotide Revenue by Country (2021-2026)
7.2 Europe Afamelanotide Sales by Type (2021-2026)
7.3 Europe Afamelanotide Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Afamelanotide by Country
8.1.1 Middle East & Africa Afamelanotide Sales by Country (2021-2026)
8.1.2 Middle East & Africa Afamelanotide Revenue by Country (2021-2026)
8.2 Middle East & Africa Afamelanotide Sales by Type (2021-2026)
8.3 Middle East & Africa Afamelanotide Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Afamelanotide
10.3 Manufacturing Process Analysis of Afamelanotide
10.4 Industry Chain Structure of Afamelanotide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Afamelanotide Distributors
11.3 Afamelanotide Customer
12 WORLD FORECAST REVIEW FOR AFAMELANOTIDE BY GEOGRAPHIC REGION
12.1 Global Afamelanotide Market Size Forecast by Region
12.1.1 Global Afamelanotide Forecast by Region (2027-2032)
12.1.2 Global Afamelanotide Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Afamelanotide Forecast by Type (2027-2032)
12.7 Global Afamelanotide Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Clinuvel Pharmaceuticals
13.1.1 Clinuvel Pharmaceuticals Company Information
13.1.2 Clinuvel Pharmaceuticals Afamelanotide Product Portfolios and Specifications
13.1.3 Clinuvel Pharmaceuticals Afamelanotide Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Clinuvel Pharmaceuticals Main Business Overview
13.1.5 Clinuvel Pharmaceuticals Latest Developments
13.2 Evonik Industries
13.2.1 Evonik Industries Company Information
13.2.2 Evonik Industries Afamelanotide Product Portfolios and Specifications
13.2.3 Evonik Industries Afamelanotide Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Evonik Industries Main Business Overview
13.2.5 Evonik Industries Latest Developments
13.3 Hangzhou Go Top Peptide Biotech
13.3.1 Hangzhou Go Top Peptide Biotech Company Information
13.3.2 Hangzhou Go Top Peptide Biotech Afamelanotide Product Portfolios and Specifications
13.3.3 Hangzhou Go Top Peptide Biotech Afamelanotide Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Hangzhou Go Top Peptide Biotech Main Business Overview
13.3.5 Hangzhou Go Top Peptide Biotech Latest Developments
13.4 Zhejiang Hengtengfu
13.4.1 Zhejiang Hengtengfu Company Information
13.4.2 Zhejiang Hengtengfu Afamelanotide Product Portfolios and Specifications
13.4.3 Zhejiang Hengtengfu Afamelanotide Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Zhejiang Hengtengfu Main Business Overview
13.4.5 Zhejiang Hengtengfu Latest Developments
13.5 Wepon
13.5.1 Wepon Company Information
13.5.2 Wepon Afamelanotide Product Portfolios and Specifications
13.5.3 Wepon Afamelanotide Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Wepon Main Business Overview
13.5.5 Wepon Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Afamelanotide Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Afamelanotide Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Subcutaneous Implants
Table 4. Major Players of Injectables
Table 5. Major Players of Transdermal Patches
Table 6. Major Players of Oral Preparations
Table 7. Major Players of Topical Preparations
Table 8. Global Afamelanotide Sales by Type (2021-2026) & (Units)
Table 9. Global Afamelanotide Sales Market Share by Type (2021-2026)
Table 10. Global Afamelanotide Revenue by Type (2021-2026) & ($ million)
Table 11. Global Afamelanotide Revenue Market Share by Type (2021-2026)
Table 12. Global Afamelanotide Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Major Players of ?-MSH Analogs
Table 14. Major Players of Acetate Derivatives
Table 15. Major Players of Free Peptide Derivatives
Table 16. Major Players of Long-Acting Modified Derivatives
Table 17. Global Afamelanotide Sales by Chemical Structure (2021-2026) & (Units)
Table 18. Global Afamelanotide Sales Market Share by Chemical Structure (2021-2026)
Table 19. Global Afamelanotide Revenue by Chemical Structure (2021-2026) & ($ million)
Table 20. Global Afamelanotide Revenue Market Share by Chemical Structure (2021-2026)
Table 21. Global Afamelanotide Sale Price by Chemical Structure (2021-2026) & (US$/Unit)
Table 22. Major Players of MC1R Selective Agonists
Table 23. Major Players of Melanin Synthesis Stimulants
Table 24. Major Players of Anti-Inflammatory Agents
Table 25. Major Players of Neuroprotective Agents
Table 26. Global Afamelanotide Sales by Pharmacological Effects (2021-2026) & (Units)
Table 27. Global Afamelanotide Sales Market Share by Pharmacological Effects (2021-2026)
Table 28. Global Afamelanotide Revenue by Pharmacological Effects (2021-2026) & ($ million)
Table 29. Global Afamelanotide Revenue Market Share by Pharmacological Effects (2021-2026)
Table 30. Global Afamelanotide Sale Price by Pharmacological Effects (2021-2026) & (US$/Unit)
Table 31. Global Afamelanotide Sale by Application (2021-2026) & (Units)
Table 32. Global Afamelanotide Sale Market Share by Application (2021-2026)
Table 33. Global Afamelanotide Revenue by Application (2021-2026) & ($ million)
Table 34. Global Afamelanotide Revenue Market Share by Application (2021-2026)
Table 35. Global Afamelanotide Sale Price by Application (2021-2026) & (US$/Unit)
Table 36. Global Afamelanotide Sales by Company (2021-2026) & (Units)
Table 37. Global Afamelanotide Sales Market Share by Company (2021-2026)
Table 38. Global Afamelanotide Revenue by Company (2021-2026) & ($ millions)
Table 39. Global Afamelanotide Revenue Market Share by Company (2021-2026)
Table 40. Global Afamelanotide Sale Price by Company (2021-2026) & (US$/Unit)
Table 41. Key Manufacturers Afamelanotide Producing Area Distribution and Sales Area
Table 42. Players Afamelanotide Products Offered
Table 43. Afamelanotide Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 44. New Products and Potential Entrants
Table 45. Market M&A Activity & Strategy
Table 46. Global Afamelanotide Sales by Geographic Region (2021-2026) & (Units)
Table 47. Global Afamelanotide Sales Market Share Geographic Region (2021-2026)
Table 48. Global Afamelanotide Revenue by Geographic Region (2021-2026) & ($ millions)
Table 49. Global Afamelanotide Revenue Market Share by Geographic Region (2021-2026)
Table 50. Global Afamelanotide Sales by Country/Region (2021-2026) & (Units)
Table 51. Global Afamelanotide Sales Market Share by Country/Region (2021-2026)
Table 52. Global Afamelanotide Revenue by Country/Region (2021-2026) & ($ millions)
Table 53. Global Afamelanotide Revenue Market Share by Country/Region (2021-2026)
Table 54. Americas Afamelanotide Sales by Country (2021-2026) & (Units)
Table 55. Americas Afamelanotide Sales Market Share by Country (2021-2026)
Table 56. Americas Afamelanotide Revenue by Country (2021-2026) & ($ millions)
Table 57. Americas Afamelanotide Sales by Type (2021-2026) & (Units)
Table 58. Americas Afamelanotide Sales by Application (2021-2026) & (Units)
Table 59. APAC Afamelanotide Sales by Region (2021-2026) & (Units)
Table 60. APAC Afamelanotide Sales Market Share by Region (2021-2026)
Table 61. APAC Afamelanotide Revenue by Region (2021-2026) & ($ millions)
Table 62. APAC Afamelanotide Sales by Type (2021-2026) & (Units)
Table 63. APAC Afamelanotide Sales by Application (2021-2026) & (Units)
Table 64. Europe Afamelanotide Sales by Country (2021-2026) & (Units)
Table 65. Europe Afamelanotide Revenue by Country (2021-2026) & ($ millions)
Table 66. Europe Afamelanotide Sales by Type (2021-2026) & (Units)
Table 67. Europe Afamelanotide Sales by Application (2021-2026) & (Units)
Table 68. Middle East & Africa Afamelanotide Sales by Country (2021-2026) & (Units)
Table 69. Middle East & Africa Afamelanotide Revenue Market Share by Country (2021-2026)
Table 70. Middle East & Africa Afamelanotide Sales by Type (2021-2026) & (Units)
Table 71. Middle East & Africa Afamelanotide Sales by Application (2021-2026) & (Units)
Table 72. Key Market Drivers & Growth Opportunities of Afamelanotide
Table 73. Key Market Challenges & Risks of Afamelanotide
Table 74. Key Industry Trends of Afamelanotide
Table 75. Afamelanotide Raw Material
Table 76. Key Suppliers of Raw Materials
Table 77. Afamelanotide Distributors List
Table 78. Afamelanotide Customer List
Table 79. Global Afamelanotide Sales Forecast by Region (2027-2032) & (Units)
Table 80. Global Afamelanotide Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Americas Afamelanotide Sales Forecast by Country (2027-2032) & (Units)
Table 82. Americas Afamelanotide Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. APAC Afamelanotide Sales Forecast by Region (2027-2032) & (Units)
Table 84. APAC Afamelanotide Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 85. Europe Afamelanotide Sales Forecast by Country (2027-2032) & (Units)
Table 86. Europe Afamelanotide Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Middle East & Africa Afamelanotide Sales Forecast by Country (2027-2032) & (Units)
Table 88. Middle East & Africa Afamelanotide Revenue Forecast by Country (2027-2032) & ($ millions)
Table 89. Global Afamelanotide Sales Forecast by Type (2027-2032) & (Units)
Table 90. Global Afamelanotide Revenue Forecast by Type (2027-2032) & ($ millions)
Table 91. Global Afamelanotide Sales Forecast by Application (2027-2032) & (Units)
Table 92. Global Afamelanotide Revenue Forecast by Application (2027-2032) & ($ millions)
Table 93. Clinuvel Pharmaceuticals Basic Information, Afamelanotide Manufacturing Base, Sales Area and Its Competitors
Table 94. Clinuvel Pharmaceuticals Afamelanotide Product Portfolios and Specifications
Table 95. Clinuvel Pharmaceuticals Afamelanotide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Clinuvel Pharmaceuticals Main Business
Table 97. Clinuvel Pharmaceuticals Latest Developments
Table 98. Evonik Industries Basic Information, Afamelanotide Manufacturing Base, Sales Area and Its Competitors
Table 99. Evonik Industries Afamelanotide Product Portfolios and Specifications
Table 100. Evonik Industries Afamelanotide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Evonik Industries Main Business
Table 102. Evonik Industries Latest Developments
Table 103. Hangzhou Go Top Peptide Biotech Basic Information, Afamelanotide Manufacturing Base, Sales Area and Its Competitors
Table 104. Hangzhou Go Top Peptide Biotech Afamelanotide Product Portfolios and Specifications
Table 105. Hangzhou Go Top Peptide Biotech Afamelanotide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Hangzhou Go Top Peptide Biotech Main Business
Table 107. Hangzhou Go Top Peptide Biotech Latest Developments
Table 108. Zhejiang Hengtengfu Basic Information, Afamelanotide Manufacturing Base, Sales Area and Its Competitors
Table 109. Zhejiang Hengtengfu Afamelanotide Product Portfolios and Specifications
Table 110. Zhejiang Hengtengfu Afamelanotide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Zhejiang Hengtengfu Main Business
Table 112. Zhejiang Hengtengfu Latest Developments
Table 113. Wepon Basic Information, Afamelanotide Manufacturing Base, Sales Area and Its Competitors
Table 114. Wepon Afamelanotide Product Portfolios and Specifications
Table 115. Wepon Afamelanotide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Wepon Main Business
Table 117. Wepon Latest Developments
Table 1. Afamelanotide Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Afamelanotide Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Subcutaneous Implants
Table 4. Major Players of Injectables
Table 5. Major Players of Transdermal Patches
Table 6. Major Players of Oral Preparations
Table 7. Major Players of Topical Preparations
Table 8. Global Afamelanotide Sales by Type (2021-2026) & (Units)
Table 9. Global Afamelanotide Sales Market Share by Type (2021-2026)
Table 10. Global Afamelanotide Revenue by Type (2021-2026) & ($ million)
Table 11. Global Afamelanotide Revenue Market Share by Type (2021-2026)
Table 12. Global Afamelanotide Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Major Players of ?-MSH Analogs
Table 14. Major Players of Acetate Derivatives
Table 15. Major Players of Free Peptide Derivatives
Table 16. Major Players of Long-Acting Modified Derivatives
Table 17. Global Afamelanotide Sales by Chemical Structure (2021-2026) & (Units)
Table 18. Global Afamelanotide Sales Market Share by Chemical Structure (2021-2026)
Table 19. Global Afamelanotide Revenue by Chemical Structure (2021-2026) & ($ million)
Table 20. Global Afamelanotide Revenue Market Share by Chemical Structure (2021-2026)
Table 21. Global Afamelanotide Sale Price by Chemical Structure (2021-2026) & (US$/Unit)
Table 22. Major Players of MC1R Selective Agonists
Table 23. Major Players of Melanin Synthesis Stimulants
Table 24. Major Players of Anti-Inflammatory Agents
Table 25. Major Players of Neuroprotective Agents
Table 26. Global Afamelanotide Sales by Pharmacological Effects (2021-2026) & (Units)
Table 27. Global Afamelanotide Sales Market Share by Pharmacological Effects (2021-2026)
Table 28. Global Afamelanotide Revenue by Pharmacological Effects (2021-2026) & ($ million)
Table 29. Global Afamelanotide Revenue Market Share by Pharmacological Effects (2021-2026)
Table 30. Global Afamelanotide Sale Price by Pharmacological Effects (2021-2026) & (US$/Unit)
Table 31. Global Afamelanotide Sale by Application (2021-2026) & (Units)
Table 32. Global Afamelanotide Sale Market Share by Application (2021-2026)
Table 33. Global Afamelanotide Revenue by Application (2021-2026) & ($ million)
Table 34. Global Afamelanotide Revenue Market Share by Application (2021-2026)
Table 35. Global Afamelanotide Sale Price by Application (2021-2026) & (US$/Unit)
Table 36. Global Afamelanotide Sales by Company (2021-2026) & (Units)
Table 37. Global Afamelanotide Sales Market Share by Company (2021-2026)
Table 38. Global Afamelanotide Revenue by Company (2021-2026) & ($ millions)
Table 39. Global Afamelanotide Revenue Market Share by Company (2021-2026)
Table 40. Global Afamelanotide Sale Price by Company (2021-2026) & (US$/Unit)
Table 41. Key Manufacturers Afamelanotide Producing Area Distribution and Sales Area
Table 42. Players Afamelanotide Products Offered
Table 43. Afamelanotide Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 44. New Products and Potential Entrants
Table 45. Market M&A Activity & Strategy
Table 46. Global Afamelanotide Sales by Geographic Region (2021-2026) & (Units)
Table 47. Global Afamelanotide Sales Market Share Geographic Region (2021-2026)
Table 48. Global Afamelanotide Revenue by Geographic Region (2021-2026) & ($ millions)
Table 49. Global Afamelanotide Revenue Market Share by Geographic Region (2021-2026)
Table 50. Global Afamelanotide Sales by Country/Region (2021-2026) & (Units)
Table 51. Global Afamelanotide Sales Market Share by Country/Region (2021-2026)
Table 52. Global Afamelanotide Revenue by Country/Region (2021-2026) & ($ millions)
Table 53. Global Afamelanotide Revenue Market Share by Country/Region (2021-2026)
Table 54. Americas Afamelanotide Sales by Country (2021-2026) & (Units)
Table 55. Americas Afamelanotide Sales Market Share by Country (2021-2026)
Table 56. Americas Afamelanotide Revenue by Country (2021-2026) & ($ millions)
Table 57. Americas Afamelanotide Sales by Type (2021-2026) & (Units)
Table 58. Americas Afamelanotide Sales by Application (2021-2026) & (Units)
Table 59. APAC Afamelanotide Sales by Region (2021-2026) & (Units)
Table 60. APAC Afamelanotide Sales Market Share by Region (2021-2026)
Table 61. APAC Afamelanotide Revenue by Region (2021-2026) & ($ millions)
Table 62. APAC Afamelanotide Sales by Type (2021-2026) & (Units)
Table 63. APAC Afamelanotide Sales by Application (2021-2026) & (Units)
Table 64. Europe Afamelanotide Sales by Country (2021-2026) & (Units)
Table 65. Europe Afamelanotide Revenue by Country (2021-2026) & ($ millions)
Table 66. Europe Afamelanotide Sales by Type (2021-2026) & (Units)
Table 67. Europe Afamelanotide Sales by Application (2021-2026) & (Units)
Table 68. Middle East & Africa Afamelanotide Sales by Country (2021-2026) & (Units)
Table 69. Middle East & Africa Afamelanotide Revenue Market Share by Country (2021-2026)
Table 70. Middle East & Africa Afamelanotide Sales by Type (2021-2026) & (Units)
Table 71. Middle East & Africa Afamelanotide Sales by Application (2021-2026) & (Units)
Table 72. Key Market Drivers & Growth Opportunities of Afamelanotide
Table 73. Key Market Challenges & Risks of Afamelanotide
Table 74. Key Industry Trends of Afamelanotide
Table 75. Afamelanotide Raw Material
Table 76. Key Suppliers of Raw Materials
Table 77. Afamelanotide Distributors List
Table 78. Afamelanotide Customer List
Table 79. Global Afamelanotide Sales Forecast by Region (2027-2032) & (Units)
Table 80. Global Afamelanotide Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Americas Afamelanotide Sales Forecast by Country (2027-2032) & (Units)
Table 82. Americas Afamelanotide Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. APAC Afamelanotide Sales Forecast by Region (2027-2032) & (Units)
Table 84. APAC Afamelanotide Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 85. Europe Afamelanotide Sales Forecast by Country (2027-2032) & (Units)
Table 86. Europe Afamelanotide Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Middle East & Africa Afamelanotide Sales Forecast by Country (2027-2032) & (Units)
Table 88. Middle East & Africa Afamelanotide Revenue Forecast by Country (2027-2032) & ($ millions)
Table 89. Global Afamelanotide Sales Forecast by Type (2027-2032) & (Units)
Table 90. Global Afamelanotide Revenue Forecast by Type (2027-2032) & ($ millions)
Table 91. Global Afamelanotide Sales Forecast by Application (2027-2032) & (Units)
Table 92. Global Afamelanotide Revenue Forecast by Application (2027-2032) & ($ millions)
Table 93. Clinuvel Pharmaceuticals Basic Information, Afamelanotide Manufacturing Base, Sales Area and Its Competitors
Table 94. Clinuvel Pharmaceuticals Afamelanotide Product Portfolios and Specifications
Table 95. Clinuvel Pharmaceuticals Afamelanotide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Clinuvel Pharmaceuticals Main Business
Table 97. Clinuvel Pharmaceuticals Latest Developments
Table 98. Evonik Industries Basic Information, Afamelanotide Manufacturing Base, Sales Area and Its Competitors
Table 99. Evonik Industries Afamelanotide Product Portfolios and Specifications
Table 100. Evonik Industries Afamelanotide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Evonik Industries Main Business
Table 102. Evonik Industries Latest Developments
Table 103. Hangzhou Go Top Peptide Biotech Basic Information, Afamelanotide Manufacturing Base, Sales Area and Its Competitors
Table 104. Hangzhou Go Top Peptide Biotech Afamelanotide Product Portfolios and Specifications
Table 105. Hangzhou Go Top Peptide Biotech Afamelanotide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Hangzhou Go Top Peptide Biotech Main Business
Table 107. Hangzhou Go Top Peptide Biotech Latest Developments
Table 108. Zhejiang Hengtengfu Basic Information, Afamelanotide Manufacturing Base, Sales Area and Its Competitors
Table 109. Zhejiang Hengtengfu Afamelanotide Product Portfolios and Specifications
Table 110. Zhejiang Hengtengfu Afamelanotide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Zhejiang Hengtengfu Main Business
Table 112. Zhejiang Hengtengfu Latest Developments
Table 113. Wepon Basic Information, Afamelanotide Manufacturing Base, Sales Area and Its Competitors
Table 114. Wepon Afamelanotide Product Portfolios and Specifications
Table 115. Wepon Afamelanotide Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Wepon Main Business
Table 117. Wepon Latest Developments
LIST OF FIGURES
Figure 1. Picture of Afamelanotide
Figure 2. Afamelanotide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Afamelanotide Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Afamelanotide Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Afamelanotide Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Afamelanotide Sales Market Share by Country/Region (2025)
Figure 10. Afamelanotide Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Subcutaneous Implants
Figure 12. Product Picture of Injectables
Figure 13. Product Picture of Transdermal Patches
Figure 14. Product Picture of Oral Preparations
Figure 15. Product Picture of Topical Preparations
Figure 16. Global Afamelanotide Sales Market Share by Type in 2026
Figure 17. Global Afamelanotide Revenue Market Share by Type (2021-2026)
Figure 18. Product Picture of ?-MSH Analogs
Figure 19. Product Picture of Acetate Derivatives
Figure 20. Product Picture of Free Peptide Derivatives
Figure 21. Product Picture of Long-Acting Modified Derivatives
Figure 22. Global Afamelanotide Sales Market Share by Chemical Structure in 2026
Figure 23. Global Afamelanotide Revenue Market Share by Chemical Structure (2021-2026)
Figure 24. Product Picture of MC1R Selective Agonists
Figure 25. Product Picture of Melanin Synthesis Stimulants
Figure 26. Product Picture of Anti-Inflammatory Agents
Figure 27. Product Picture of Neuroprotective Agents
Figure 28. Global Afamelanotide Sales Market Share by Pharmacological Effects in 2026
Figure 29. Global Afamelanotide Revenue Market Share by Pharmacological Effects (2021-2026)
Figure 30. Afamelanotide Consumed in Hematologic Disorders
Figure 31. Global Afamelanotide Market: Hematologic Disorders (2021-2026) & (Units)
Figure 32. Afamelanotide Consumed in Skin Pigmentary Disorders
Figure 33. Global Afamelanotide Market: Skin Pigmentary Disorders (2021-2026) & (Units)
Figure 34. Afamelanotide Consumed in Acute Diseases
Figure 35. Global Afamelanotide Market: Acute Diseases (2021-2026) & (Units)
Figure 36. Afamelanotide Consumed in Autoimmune Diseases
Figure 37. Global Afamelanotide Market: Autoimmune Diseases (2021-2026) & (Units)
Figure 38. Afamelanotide Consumed in Neurodegenerative Diseases
Figure 39. Global Afamelanotide Market: Neurodegenerative Diseases (2021-2026) & (Units)
Figure 40. Global Afamelanotide Sale Market Share by Application (2025)
Figure 41. Global Afamelanotide Revenue Market Share by Application in 2026
Figure 42. Afamelanotide Sales by Company in 2026 (Units)
Figure 43. Global Afamelanotide Sales Market Share by Company in 2026
Figure 44. Afamelanotide Revenue by Company in 2026 ($ millions)
Figure 45. Global Afamelanotide Revenue Market Share by Company in 2026
Figure 46. Global Afamelanotide Sales Market Share by Geographic Region (2021-2026)
Figure 47. Global Afamelanotide Revenue Market Share by Geographic Region in 2026
Figure 48. Americas Afamelanotide Sales 2021-2026 (Units)
Figure 49. Americas Afamelanotide Revenue 2021-2026 ($ millions)
Figure 50. APAC Afamelanotide Sales 2021-2026 (Units)
Figure 51. APAC Afamelanotide Revenue 2021-2026 ($ millions)
Figure 52. Europe Afamelanotide Sales 2021-2026 (Units)
Figure 53. Europe Afamelanotide Revenue 2021-2026 ($ millions)
Figure 54. Middle East & Africa Afamelanotide Sales 2021-2026 (Units)
Figure 55. Middle East & Africa Afamelanotide Revenue 2021-2026 ($ millions)
Figure 56. Americas Afamelanotide Sales Market Share by Country in 2026
Figure 57. Americas Afamelanotide Revenue Market Share by Country (2021-2026)
Figure 58. Americas Afamelanotide Sales Market Share by Type (2021-2026)
Figure 59. Americas Afamelanotide Sales Market Share by Application (2021-2026)
Figure 60. United States Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 61. Canada Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 62. Mexico Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 63. Brazil Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 64. APAC Afamelanotide Sales Market Share by Region in 2026
Figure 65. APAC Afamelanotide Revenue Market Share by Region (2021-2026)
Figure 66. APAC Afamelanotide Sales Market Share by Type (2021-2026)
Figure 67. APAC Afamelanotide Sales Market Share by Application (2021-2026)
Figure 68. China Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 69. Japan Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 70. South Korea Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 71. Southeast Asia Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 72. India Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 73. Australia Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 74. China Taiwan Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 75. Europe Afamelanotide Sales Market Share by Country in 2026
Figure 76. Europe Afamelanotide Revenue Market Share by Country (2021-2026)
Figure 77. Europe Afamelanotide Sales Market Share by Type (2021-2026)
Figure 78. Europe Afamelanotide Sales Market Share by Application (2021-2026)
Figure 79. Germany Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 80. France Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 81. UK Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 82. Italy Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 83. Russia Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 84. Middle East & Africa Afamelanotide Sales Market Share by Country (2021-2026)
Figure 85. Middle East & Africa Afamelanotide Sales Market Share by Type (2021-2026)
Figure 86. Middle East & Africa Afamelanotide Sales Market Share by Application (2021-2026)
Figure 87. Egypt Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 88. South Africa Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 89. Israel Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 90. Turkey Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 91. GCC Countries Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 92. Manufacturing Cost Structure Analysis of Afamelanotide in 2026
Figure 93. Manufacturing Process Analysis of Afamelanotide
Figure 94. Industry Chain Structure of Afamelanotide
Figure 95. Channels of Distribution
Figure 96. Global Afamelanotide Sales Market Forecast by Region (2027-2032)
Figure 97. Global Afamelanotide Revenue Market Share Forecast by Region (2027-2032)
Figure 98. Global Afamelanotide Sales Market Share Forecast by Type (2027-2032)
Figure 99. Global Afamelanotide Revenue Market Share Forecast by Type (2027-2032)
Figure 100. Global Afamelanotide Sales Market Share Forecast by Application (2027-2032)
Figure 101. Global Afamelanotide Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Afamelanotide
Figure 2. Afamelanotide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Afamelanotide Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Afamelanotide Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Afamelanotide Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Afamelanotide Sales Market Share by Country/Region (2025)
Figure 10. Afamelanotide Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Subcutaneous Implants
Figure 12. Product Picture of Injectables
Figure 13. Product Picture of Transdermal Patches
Figure 14. Product Picture of Oral Preparations
Figure 15. Product Picture of Topical Preparations
Figure 16. Global Afamelanotide Sales Market Share by Type in 2026
Figure 17. Global Afamelanotide Revenue Market Share by Type (2021-2026)
Figure 18. Product Picture of ?-MSH Analogs
Figure 19. Product Picture of Acetate Derivatives
Figure 20. Product Picture of Free Peptide Derivatives
Figure 21. Product Picture of Long-Acting Modified Derivatives
Figure 22. Global Afamelanotide Sales Market Share by Chemical Structure in 2026
Figure 23. Global Afamelanotide Revenue Market Share by Chemical Structure (2021-2026)
Figure 24. Product Picture of MC1R Selective Agonists
Figure 25. Product Picture of Melanin Synthesis Stimulants
Figure 26. Product Picture of Anti-Inflammatory Agents
Figure 27. Product Picture of Neuroprotective Agents
Figure 28. Global Afamelanotide Sales Market Share by Pharmacological Effects in 2026
Figure 29. Global Afamelanotide Revenue Market Share by Pharmacological Effects (2021-2026)
Figure 30. Afamelanotide Consumed in Hematologic Disorders
Figure 31. Global Afamelanotide Market: Hematologic Disorders (2021-2026) & (Units)
Figure 32. Afamelanotide Consumed in Skin Pigmentary Disorders
Figure 33. Global Afamelanotide Market: Skin Pigmentary Disorders (2021-2026) & (Units)
Figure 34. Afamelanotide Consumed in Acute Diseases
Figure 35. Global Afamelanotide Market: Acute Diseases (2021-2026) & (Units)
Figure 36. Afamelanotide Consumed in Autoimmune Diseases
Figure 37. Global Afamelanotide Market: Autoimmune Diseases (2021-2026) & (Units)
Figure 38. Afamelanotide Consumed in Neurodegenerative Diseases
Figure 39. Global Afamelanotide Market: Neurodegenerative Diseases (2021-2026) & (Units)
Figure 40. Global Afamelanotide Sale Market Share by Application (2025)
Figure 41. Global Afamelanotide Revenue Market Share by Application in 2026
Figure 42. Afamelanotide Sales by Company in 2026 (Units)
Figure 43. Global Afamelanotide Sales Market Share by Company in 2026
Figure 44. Afamelanotide Revenue by Company in 2026 ($ millions)
Figure 45. Global Afamelanotide Revenue Market Share by Company in 2026
Figure 46. Global Afamelanotide Sales Market Share by Geographic Region (2021-2026)
Figure 47. Global Afamelanotide Revenue Market Share by Geographic Region in 2026
Figure 48. Americas Afamelanotide Sales 2021-2026 (Units)
Figure 49. Americas Afamelanotide Revenue 2021-2026 ($ millions)
Figure 50. APAC Afamelanotide Sales 2021-2026 (Units)
Figure 51. APAC Afamelanotide Revenue 2021-2026 ($ millions)
Figure 52. Europe Afamelanotide Sales 2021-2026 (Units)
Figure 53. Europe Afamelanotide Revenue 2021-2026 ($ millions)
Figure 54. Middle East & Africa Afamelanotide Sales 2021-2026 (Units)
Figure 55. Middle East & Africa Afamelanotide Revenue 2021-2026 ($ millions)
Figure 56. Americas Afamelanotide Sales Market Share by Country in 2026
Figure 57. Americas Afamelanotide Revenue Market Share by Country (2021-2026)
Figure 58. Americas Afamelanotide Sales Market Share by Type (2021-2026)
Figure 59. Americas Afamelanotide Sales Market Share by Application (2021-2026)
Figure 60. United States Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 61. Canada Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 62. Mexico Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 63. Brazil Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 64. APAC Afamelanotide Sales Market Share by Region in 2026
Figure 65. APAC Afamelanotide Revenue Market Share by Region (2021-2026)
Figure 66. APAC Afamelanotide Sales Market Share by Type (2021-2026)
Figure 67. APAC Afamelanotide Sales Market Share by Application (2021-2026)
Figure 68. China Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 69. Japan Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 70. South Korea Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 71. Southeast Asia Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 72. India Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 73. Australia Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 74. China Taiwan Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 75. Europe Afamelanotide Sales Market Share by Country in 2026
Figure 76. Europe Afamelanotide Revenue Market Share by Country (2021-2026)
Figure 77. Europe Afamelanotide Sales Market Share by Type (2021-2026)
Figure 78. Europe Afamelanotide Sales Market Share by Application (2021-2026)
Figure 79. Germany Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 80. France Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 81. UK Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 82. Italy Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 83. Russia Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 84. Middle East & Africa Afamelanotide Sales Market Share by Country (2021-2026)
Figure 85. Middle East & Africa Afamelanotide Sales Market Share by Type (2021-2026)
Figure 86. Middle East & Africa Afamelanotide Sales Market Share by Application (2021-2026)
Figure 87. Egypt Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 88. South Africa Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 89. Israel Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 90. Turkey Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 91. GCC Countries Afamelanotide Revenue Growth 2021-2026 ($ millions)
Figure 92. Manufacturing Cost Structure Analysis of Afamelanotide in 2026
Figure 93. Manufacturing Process Analysis of Afamelanotide
Figure 94. Industry Chain Structure of Afamelanotide
Figure 95. Channels of Distribution
Figure 96. Global Afamelanotide Sales Market Forecast by Region (2027-2032)
Figure 97. Global Afamelanotide Revenue Market Share Forecast by Region (2027-2032)
Figure 98. Global Afamelanotide Sales Market Share Forecast by Type (2027-2032)
Figure 99. Global Afamelanotide Revenue Market Share Forecast by Type (2027-2032)
Figure 100. Global Afamelanotide Sales Market Share Forecast by Application (2027-2032)
Figure 101. Global Afamelanotide Revenue Market Share Forecast by Application (2027-2032)
